IOL Chemicals And Pharmaceuticals Ltd Stock Analysis

BSE: 524164 | NSE: IOLCP | Pharmaceuticals & Drugs | Small Cap

BSE Share Price May 20, 16:59
395.00 12.50 (3.27%)

DeciZen - Make an Informed Decision on IOL Chem & Pharma

Overall Rating

1. Quality

2. Valuation

Fair

3. Price Trend

FAQs

1. Is IOL Chemicals And Pharmaceuticals Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that IOL Chemicals And Pharmaceuticals Ltd is a average quality company.

2. Is IOL Chemicals And Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of IOL Chemicals And Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is IOL Chemicals And Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of IOL Chemicals And Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of IOL Chem & Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
IOL Chemicals And Pharmaceuticals Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
ROCE % 6.4%7.1%8%-4.3%0.5%8.2%11%38.3%45.4%41.7%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 4714825643855807119831,6851,8941,9672,072
YoY Gr. Rt. %-2.3%17%-31.7%50.9%22.4%38.4%71.4%12.4%3.8%-
Adj EPS 1.70.31.2-14-7.10.94.540.662.474.936.3
YoY Gr. Rt. %--84.6%342.3%-1316.5%NANA423.5%812.6%53.6%20.1%-
BVPS (₹) 65.464.265.742.232.933.638.481.7141.4214.7236
Adj Net Profit 4.30.73.3-66.7-404.825231355440213
Cash Flow from Ops. 54.953.278.4-4717.783.3120273471380-
Debt/CF from Ops. 7.27.54.6-8.525.65.43.510.10-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 17.2%27.7%26%3.8%
Adj EPS 52.4%NA156.3%20.1%
BVPS 14.145.577.551.9
Share Price 32.1% 44.7% 29.6% -36.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity % 2.50.41.7-32-20.42.612.46755.142.416.1
Op. Profit Mgn % 14.618.5172.98.914.412.224.330.330.115.7
Net Profit Mgn % 0.90.10.6-17.3-6.90.72.513.718.722.410.3
Debt to Equity 2.32.31.722.42.420.60.10-
Working Cap Days 1381561582441811781491041201420
Cash Conv. Cycle 83102120199156117704340440

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 26.00%

Net Profit is growing at healthy rate in last 3 years 156.29%

Return on Equity has declined versus last 3 years average to 16.10%

Sales growth is not so good in last 4 quarters at 6.50%

Latest Financials - IOL Chemicals And Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 36.3 -
TTM Sales (₹ Cr.) 2,072 -
BVPS (₹.) 236 -
Reserves (₹ Cr.) 1,327 -
P/BV 1.62 -
PE 10.53 -
From the Market
52 Week Low / High (₹) 295.10 / 725.00
All Time Low / High (₹) 0.33 / 898.40
Market Cap (₹ Cr.) 2,245
Equity (₹ Cr.) 58.7
Face Value (₹) 10
Industry PE 36.1

Management X-Ray of IOL Chem & Pharma :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Analyst's Notes

News

About IOL Chemicals And Pharmaceuticals Ltd

IOL Chemicals and Pharmaceuticals (IOLCP) is a leading organic chemicals manufacturers and suppliers. They are Indian manufacturer of industrial chemicals & bulk drugs for over two decades, by pursuing & implementing the highest standards of excellence in their operations, they have nurtured their capabilities by delivering consistent results and have earned the admiration of customers and stakeholders alike.

IOLCP has attained a front line position in the domestic segment and is thus contemplating to widen its horizon through global penetration. It has overseas customers from various countries like Bangladesh, Thailand, UAE, Syria, Singapore, Hong Kong, Pakistan, Egypt and many others.

IOLCP is therefore moving ahead with its vision to develop global strategic alliances with quality leaders and expand into new markets.

Product range of the company includes:

  • Acetic AcidWith a production capacity of 6.5 million metric tonnes, Acetic Acid is a significant chemical reagent & industrial chemical with a wide spectrum of applications.
  • Ethyl Acetate Ethyl Acetate is a significant industrial solvent with diverse industrial applications.
  • Acetic AnhydrideAcetic Anhydride is a well-known acid anhydride that is widely used in pharmaceutical & agrochemical industries.
  • Isobutyl BenzeneThis specialty chemical is used as an intermediate in Ibuprofen and other anti-inflammatory analgesic bulk drug
  • Mono Chloro Acetic AcidAlso know as Chloro Acetic Acid it is used in agrochemicals, pesticides, insecticides, organic chemicals etc.
  • Acetyl ChlorideAcetyl Chlorideis is colourless, near to pale yellow liquid that is used in perfume, dye, chemical, pharmaceutical bulk drugs and intermediates.
  • Ibuprofen A non-steroidal anti-inflammatory drug, Ibuprofen is used in the treatment of a variety of ailments such as arthritis, dysmenorrhoea, and is also used an analgesic.  

Clientele:

They have strong business relationships with a number of prestigious clients such as Ranbaxy Labs, CIPLA, Flex Industries, ICI Paints, Asian Paints, Pidilite, Rallis India, Hindustan Polymide, Gujarat Super Phosphate, & Avon Organics etc.

Awards & Achievements:

  • IOL Chemicals & Pharmaceuticals has consecutively been bestowed with the 2nd Prize in Chemical Sector-National Energy Conservation Award 2007, by the Ministry of Power, Government of India for the third time in a row for its efforts made towards new technology implementation to conserve the energy resources of the company.
  • IOLCP has also won Kamla Dial Gold Standard for North-West Qual Tech Standards-2006 conducted by Qimpro College Mumbai.
  • One star Export House Status Award.
  • National Energy Conservation Award 2007.
  • National Energy Conservation Award 2006.
  • National Energy Conservation Award 2005.
  • One star export House Status Award.
  • Halal Certification.
  • Kosher Certification.
  • USFDA Certification.
  • EDQM Certification.

Future Plans:

  • Chemicals Expansion - The company has planned for increasing the capacity of Acetic Acid from 50000 TPA to 66000 TPA, Ethyl Acetate from 33000 TPA to 36000 TPA & Capacity of Acetic Anhydride from 12000 TPA to 18000 TPA.
  • Pharma Expansion -  IOLCP recently boosted its Ibuprofen plant capacity to 3600 TPA from 1800 TPA and to further expand the capacity to 6000 TPA.
  • PPI's - The company has planned for installation of new manufacturing facilities of following PPIs:-Rabeprazole -Lansoprazole -Omeprazole -Pantoprazole -Esomeprazole. With annual installed capacity of 360 MT, the commercial production will start by the end of 2008.
  • Co-generation Power Plant  - To meet out its enhanced energy requirement and to become self reliance the company has also proposed for another captive co-generation plant with additional capacity of 13 MW in addition to the existing cogeneration plant of 4 MW capacity.
  • Forward Integration - The company has planned for adding two more products i.e. Mono Chloro Acetic Acid(MCA) with a capacity of 6600 TPA & Acetyl Chloride with a capacity of 4800 TPA , using Acetic Anhydride & Acetic Acid as a raw material.
  • Backward Integration - The company has planned for setting up plant for Iso-butyl Benzene(IBB) with a capacity of 6000 TPA which will be the raw material for the manufacturing of Ibuprofen.
  • Research & Development  - To develop new Molecules and process development
Read More Read Less